p ositron emission tomography (PET) technology has matured over recent years to become an established imaging modality for the noninvasive characterization of cardiac disease. Significant advances in scintigraphic data acquisition with multi-slice PET instrumentation allow three-dimensional determination of regional tissue tracer concentration. Furthermore, an abundance of radiopharmaceuticals labeled with carbon-ll (nC), nitrogen-13 (13N), oxygen-15 (150), or fluorine-18 (~SF) provide sophisticated delineation of specific tissue functions. The temporal definition of tissue tracer kinetics and subsequent analysis with mathematical models enable quantitative measurements of physiologic processes such as blood flow and metabolic rates.
Although coronary angiography is considered to be the "gold standard" for the characterization of coronary artery disease (CAD), data increasingly support the importance of noninvasively assessing the functional definition of the severity and extent of the disease process) Regional measurements such as absolute or relative coronary reserve have been shown to provide a sensitive marker for the functional significance of coronary artery stenoses. Such measurements represent functional correlates to the anatomic definition of vascular abnormalities occurring in CAD. Although these measurements can be obtained invasively by several methods, at the present time PET represents the only noninvasive approach that accurately quantifies regional myocardial perfusion. 2 ' 3 This review addresses the clinical role of blood flow imaging with PET for the detection of CAD, using qualitative evaluation of regional tracer distribution. Additionally, current methods of quantification of regional myocardial blood flow under various physiologic conditions are compared.
RADIOPHARMACEUTICALS
Several blood flow tracers are available for the evaluation of myocardial perfusion using PET (Table I) . Based on the mode of production, these radiopharmaceuticals are divided into two groups. 
Rubidium-82 ([SZRb]-) and copper-62 ([62Cu]-) pyru-

Generator.produced flow tracers:
The strontium-82 (SZSr)fl2Rb generator-produced flow tracer is commercially available. The radiopharmaceutical 8ZRb, recently approved by the U.S. Food and Drug Administration for the evaluation of myocardial blood flow, 4 is currently the most practical tracer available for PET imaging. The 8ZSr/82Rb generator is being used in combination with a dedicated infusion system, which permits safe and reproducible administration of 82Rb with minimal radiation exposure to the technical staff ( Figure 1 ). The short physical half-life of 8ZRb (76 seconds) allows blood flow measurements in short time intervals. By combining the use of 82Rb with pharmacologic stress testing, regional myocardial flow reserve can be evaluated in about 1 hour, which compares very favorably with the time required for the acquisition of thallium-201 (/°ITI) or technetium99m (99mTC) isonitrile single-photon emission computed tomography (SPECT) stress studies.
The practical advantages of 82Rb are somewhat offset by the physiologic and physical properties of this tracer. The myocardial extraction fraction of 82Rb is lower than that of 2°IT1, and it decreases considerably with increasing blood flow. Therefore, high flow rates produce inaccurate measurements due to the nonlinear relationship between 82Rb tissue retention and blood flow. Furthermore, 82Rb emits positrons with an energy of 3.3 MeV that travel a longer distance than those of 13N or I IC in tissue before they annihilate with electrons.
Thus, the image resolution obtainable with 82Rb is less than that available with [~3N]NH3 (Table I) . However, the loss of resolution by the high energy of 82Rb positrons is small in comparison to the effect of cardiac motion on the spatial resolution of nongated cardiac images. [62Cu]PTSM represents a newly introduced flow tracer produced with the zinc-62 (62Zn)/62Cu generator. Although this radiotracer has been validated only in experimental studies, the preliminary resuits are promising. 5 62Cu has a physical half-life of 9.8 minutes and, like S2Rb, exhibits a high positron energy (Table I ). The myocardial extraction of PTSM is similar to that of 82Rb, and the clearance from myocardial tissue is slow--both desirable characteristics for blood flow imaging. The usable time period for a 62Zn/6ZCu generator is only about 24 hours, in contrast to the 82Sr/S2Rb generator, which has a shelf life of about 6 weeks. This may limit its distribution, as well as the availability of a continuous supply of compounds for the evaluation of myocardial blood flow. However, in combination with a centrally located cyclotron, generator- from the myocardium is slow, and yields a high contrast between myocardial and blood activity. 
QUALITATIVE EVALUATION OF MYOCARDIAL PERFUSION
Qualitative evaluation of regional tracer distribution using 82Rb and 13N has been employed to detect CAD. Taking advantage of the attenuation correction provided by PET, relative tracer concentration is more homogeneous throughout crosssectional images of normal myocardium, as compared to 2°iT1 SPECT imaging ( Figure 3 ). Recently published normal data for regional 2°lTI retention on SPECT images demonstrate considerable variation between the anterior and inferior walls of the left ventricle in a male population, thus indicating the significant effect of photon attenuation: Attenuation artifacts are common with 2°~TI SPECT imaging and may limit the specificity of this test for the diagnosis of CAD. PET evaluation of myocardial perfusion at rest and during stress provides detection of regional perfusion abnormalities with high diagnostic accuracy ( Figure 4 formed following pharmacologic coronary vasodilatation (dipyridamole, adenosine) because the combination of PET with exercise poses technical difficulties, especially if the short-lived tracer 82Rb is employed. PET imaging together with 2°iT1 SPECT in patients with angiographically proven CAD. Both imaging procedures yielded a high sensitivity for the regional detection of disease. However, this study did not include a normal control population; thus, no conclusions can be drawn about the specificity of both imaging modalities.
More recently, two investigations compared S2Rb PET imaging with 2°1T1 SPECT imaging in the same patient population. In the first study of 132 patients, Go et a112 from the Cleveland Clinic reported a significantly higher diagnostic accuracy of 82Rb PET imaging for the detection of CAD. Sensitivity and specificity of 82Rb PET were higher than those of 2°lT1 SPECT and yielded a significantly improved diagnostic accuracy of 92% for PET as compared with 76% for SPECT. Both imaging procedures followed a single infusion of dipyridamole, thus avoiding the variability of repeated stress testing in the study population. The results of the second study, performed at the University of Michigan, failed to confirm the higher sensitivity of 82Rb PET for detection of CAD. 1~ Both PET and SPECT identified disease correctly in about 85% of the cases. However, PET significantly out-performed SPECT in terms of specificity (Table II) . The overall diagnostic accuracy of PET and SPECT agreed closely with the data obtained by Go et alJ 2 Although patient selection for cardiac catheterization may explain the low specificity of 2°~TI SPECT described by the Michigan study, several recent studies indicate the relatively high incidence of false-positive 2°~TI SPECT resultsJ 4' 15 82Rb PET showed a significantly lower rate of false-positive findings in the same patient population. The diagnostic difference was most obvious in the diagnosis of disease involving the inferior wall of the left ventricle. Diaphragmatic attenuation artifacts appear to be less common with 82Rb PET imaging, which clearly indicates the limitations of the low energy tracer 2°1T1 for SPECT imaging. Future use of 99mTc-labeled radiopharmaceuticals may overcome some of these limitations, but sophisticated attenuation correction of SPECT images may be required to match the advanced imaging technology provided by PET instrumentation.
Thus, PET in combination with 82Rb or []3N]NH3 yields higher diagnostic accuracy for detection of CAD as compared to 2°tTl SPECT. This primarily reflects the improvement of scintigraphic data acquisition provided by PET. Preliminary studies analyzing the cost of PET imaging and its impact on the management of patients with proven or suspected CAD suggest an overall cost-saving effect due to less unnecessary cardiac catheterization.~6 However, the question remains whether the higher diagnostic accuracy of this modality justifies the increased costs involved with this test. Further investigation will define the economic cost-benefit ratio of PET flow imaging for detection of CAD.
QUANTIFICATION OF MYOCARDIAL BLOOD FLOW BY PET
As outlined above, PET provides the most sophisticated technology to quantify regional tracer concentration in the myocardium. The time course of tracer distribution in myocardium and blood can be defined by using dynamic image acquisition. The most commonly used flow tracers are [13N]NH3 and [150]H20. In order to quantify myocardial blood flow in units of ml/min/100 g, the accumulation and fate of the radiopharmaceutical in myocardial tissue must be described by appropriate mathematical models. The exchange of tracer between vascular space and tissue is commonly described in terms of compartmental models. These models rely on two basic assumptions: first, the tracer is homogeneously distributed in these compartments; and second, the transfer from compartments occurs with conservation of mass. Theory and application of compartmental analysis require the development of a current model for the behavior of any particular tracer in the biologic system. Knowledge about the physiologic behavior of the tracer should provide justification for the specific structure as well as the parameters of the compartmental model.
The configurations of compartmental models used frequently for quantification of blood flow are shown in Figure 5 . The two-compartmental model consists of a vascular as well as an extravascular compartment. It is most applicable to the description of the tracer kinetics of freely diffusable blood flow tracers such as [150]H20. The injected tracer is delivered by the vascular space, diffuses immediately across the membrane, and equilibrates within the tissue. The exchange between the two compartments is expressed by the rate constants Ks and k 2. In case of freely diffusable tracers, values for blood flow are usually derived from the estimation of ks, which represents the clearance of activity from tissueJ 7
In contrast, the description of tissue kinetics for
[13N]NH3 requires a more complex three-compartmental model ( Figure 5 ). The vascular compartment represents the tracer concentration in plasma that the effect of t3N metabolites in blood on myocardial blood flow measurements is relatively small, and correction for metabolic contamination may not be necessary. 3 The major advantage of [150]H20 is that blood flow measurements are less affected by partial volume effect. The spatial resolution provided by current PET instrumentation ranges between 6 and 10 mm. In the human heart, the left ventricular wall thickness averages between 10 to 20 mm, depending on the degree of wall thickening during the cardiac cycle. Thus, the recovery of tracer information from the left ventricular wall is ini]uenced by partial volume effect. Undersampllng becomes most prominent if the left ventricular wall is thinned, such as in patients with previous myocardial infarction or severe contractile dysfunction. Although clearance kinetics are less sensitive to partial volume effects, Monte-Carlo simulations have shown that the coefficient of variation for a washout rate constant is about 3 times higher than the same coefficient for an uptake rate constant. It is obvious that further research is required to define the relative error sensitivity of uptake pa- It is expected that myocardial blood flow can also be quantified using [S2Rb]-and [62Cu]PTSM. Current research is focusing on the development of a kinetic model for 82Rb. The kinetics of 82Rb resemble those of 2°~TI. However, the short half-life of this tracer requires PET instrumentation with high sensitivity and count-rate capabilities for the accurate definition of time-activity curves. (Table IV) . The relative increase of myocardial blood flow (coronary reserve) in normal volunteers was greater than 4 to 1, which again agrees closely with independent measures of coronary reserve by Doppler catheters and studies performed in the animal model. 1 Quantitative flow measurements during stress (Table IV) indicate that the increase in myocardial blood flow is greater following dipyridamole infusion than following exercise. This may reflect the difficulty of reaching adequate cardiac workload with bicycle exercise during PET imaging. 2°
APPUCATION OF qUANTITATIVE FLOW MEASUREMENTS BY PET
The noninvasive determination of coronary reserve by pharmacologic means may provide a useful and reproducible parameter for the func- studied patients undergoing coronary angioplasty prior to and following this procedure. The coronary reserve averaged 1.3 in the stenotic area prior to angioplasty but increased to 3.3, 5 days after revascularization. Thus, quantitative flow measurements may be used following angioplasty for the objective assesment of the intervention results, and also as a predictive parameter for restenosis. In addition to useful diagnostic and prognostic information in patients with CAD, quantitative flow measurements can also provide an objective assessment of drug therapy. Such measurements can also be applied in cardiac diseases characterized by global changes in blood flow.
Flow measurements based on relative tracer distribution are of limited use in such disease groups. In patients with chest pain and normal coronary arteries, [tsO]H20 blood flow measurements have been shown to identify decreased coronary reserve. 3° Thus, among angina patients, PET may provide a unique diagnostic means to identify those patients with presumably smallvessel CAD.
Quantitative flow measurements have also been employed in patients with cardiac transplants. 3t Few studies have suggested that the coronary reserve is reduced in patients with transplant rejection. This indicates altered coronary hemodynamics, with further studies required to define the diagnostic yield of such measurements in the follow-up of patients with cardiac transplantation.
Although the coronary reserve represents a sophisticated tool to describe the functional state of the coronary vasculature, its magnitude is affected by physiologic processes. For example, elevated blood pressure and heart rate increase resting blood flow and decrease coronary reserve. 32 On the other hand, pharmacologic action of dipyridamole or adenosine may be attenuated in some patients, especially if they take medications known to interact with these drugs. Therefore, the interpretation of flow measurements in patients with various cardiac diseases requires careful consideration of all factors which may affect the magnitude of global and regional coronary reserve.
CONCLUSION
PET provides an advanced imaging technology that allows the accurate definition of regional tracer distribution. This technology, in combination with 82Rb and [t3N]NH3, allows for the sensitive and specific detection of CAD. Several studies indicate the superiority of this approach in comparison to standard 2°ITI SPECT imaging. However, further studies are needed to define the costbenefit ratio of this technology for the management of patients with suspected or proven CAD.
PET represents the most accurate noninvasive means to measure regional blood flow and can be used in combination with pharmacologic stress tests to quantify regional coronary reserve. Tracer kinetic models for [UN]NH3 and [tSO]H20 provide accurate flow estimates over a wide flow range. Quantitative flow measurements by PET provide a sophisticated tool for research and clinical characterization of patients with CAD. Short-lived radiopharmaceuticals used for PET allow the combined evaluation of flow and other tissue functions such as metabolism, which may prove useful in the assessment of the extent and severity of myocardial disease.
